HEADER    HORMONE                                 25-APR-18   6GE2              
TITLE     EXENDIN-4 BASED DUAL GLP-1/GLUCAGON RECEPTOR AGONIST                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: EXENDIN-4;                                                 
COMPND   3 CHAIN: A;                                                            
COMPND   4 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: HELODERMA SUSPECTUM;                            
SOURCE   4 ORGANISM_COMMON: GILA MONSTER;                                       
SOURCE   5 ORGANISM_TAXID: 8554                                                 
KEYWDS    HORMONE                                                               
EXPDTA    SOLUTION NMR                                                          
NUMMDL    10                                                                    
AUTHOR    A.EVERS,M.KURZ                                                        
REVDAT   3   08-MAY-19 6GE2    1       REMARK                                   
REVDAT   2   25-JUL-18 6GE2    1       JRNL                                     
REVDAT   1   20-JUN-18 6GE2    0                                                
JRNL        AUTH   A.EVERS,M.BOSSART,S.PFEIFFER-MAREK,R.ELVERT,H.SCHREUDER,     
JRNL        AUTH 2 M.KURZ,S.STENGELIN,M.LORENZ,A.HERLING,A.KONKAR,U.LUKASCZYK,  
JRNL        AUTH 3 A.PFENNINGER,K.LORENZ,T.HAACK,D.KADEREIT,M.WAGNER            
JRNL        TITL   DUAL GLUCAGON-LIKE PEPTIDE 1 (GLP-1)/GLUCAGON RECEPTOR       
JRNL        TITL 2 AGONISTS SPECIFICALLY OPTIMIZED FOR MULTIDOSE FORMULATIONS.  
JRNL        REF    J. MED. CHEM.                 V.  61  5580 2018              
JRNL        REFN                   ISSN 1520-4804                               
JRNL        PMID   29879354                                                     
JRNL        DOI    10.1021/ACS.JMEDCHEM.8B00292                                 
REMARK   2                                                                      
REMARK   2 RESOLUTION. NOT APPLICABLE.                                          
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : SYBYL 2.1.1                                          
REMARK   3   AUTHORS     : TRIPOS                                               
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 6GE2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-APR-18.                  
REMARK 100 THE DEPOSITION ID IS D_1200009812.                                   
REMARK 210                                                                      
REMARK 210 EXPERIMENTAL DETAILS                                                 
REMARK 210  EXPERIMENT TYPE                : NMR                                
REMARK 210  TEMPERATURE           (KELVIN) : 310                                
REMARK 210  PH                             : 5.0                                
REMARK 210  IONIC STRENGTH                 : 35MM SODIUM PHOSPHATE              
REMARK 210  PRESSURE                       : 1 PA                               
REMARK 210  SAMPLE CONTENTS                : 5 MG/ML PEPTIDE 12,                
REMARK 210                                   TRIFLUOROETHANOL/WATER             
REMARK 210                                                                      
REMARK 210  NMR EXPERIMENTS CONDUCTED      : 2D 1H-1H COSY; 2D 1H-1H TOCSY;     
REMARK 210                                   2D 1H-1H NOESY; 2D 1H-13C HSQC     
REMARK 210  SPECTROMETER FIELD STRENGTH    : 700 MHZ; 500 MHZ                   
REMARK 210  SPECTROMETER MODEL             : 1; 2                               
REMARK 210  SPECTROMETER MANUFACTURER      : BRUKER                             
REMARK 210                                                                      
REMARK 210  STRUCTURE DETERMINATION.                                            
REMARK 210   SOFTWARE USED                 : TOPSPIN 3.2, CARA 1.8.4.2          
REMARK 210   METHOD USED                   : MOLECULAR DYNAMICS                 
REMARK 210                                                                      
REMARK 210 CONFORMERS, NUMBER CALCULATED   : 20                                 
REMARK 210 CONFORMERS, NUMBER SUBMITTED    : 10                                 
REMARK 210 CONFORMERS, SELECTION CRITERIA  : STRUCTURES WITH THE LEAST          
REMARK 210                                   RESTRAINT VIOLATIONS               
REMARK 210                                                                      
REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1                   
REMARK 210                                                                      
REMARK 210 REMARK: NULL                                                         
REMARK 215                                                                      
REMARK 215 NMR STUDY                                                            
REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION           
REMARK 215 NMR DATA.  PROTEIN DATA BANK CONVENTIONS REQUIRE THAT                
REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON              
REMARK 215 THESE RECORDS ARE MEANINGLESS.                                       
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 120 ANGSTROM**2                           
REMARK 350 SURFACE AREA OF THE COMPLEX: 3870 ANGSTROM**2                        
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL                          
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES                                       
REMARK 500                                                                      
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
REMARK 500                                                                      
REMARK 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
REMARK 500  1 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.2 DEGREES          
REMARK 500  2 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.0 DEGREES          
REMARK 500  3 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.1 DEGREES          
REMARK 500  5 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.3 DEGREES          
REMARK 500  6 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.5 DEGREES          
REMARK 500  7 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -4.8 DEGREES          
REMARK 500  8 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.2 DEGREES          
REMARK 500  9 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.0 DEGREES          
REMARK 500 10 TRP A  25   CE2 -  CD2 -  CG  ANGL. DEV. =  -5.1 DEGREES          
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500  4 LEU A  21      -70.30    -57.97                                   
REMARK 500  4 PHE A  22      -64.43    -26.25                                   
REMARK 500  5 THR A   5      -81.12     60.62                                   
REMARK 500  9 PHE A  22      -62.03    -28.08                                   
REMARK 500 10 THR A   5      -61.89   -147.81                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue EVT A 101                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for Ligand residues AIB A 34          
REMARK 800  through LYS A 35 bound to SER A 33                                  
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: 34266   RELATED DB: BMRB                                 
REMARK 900 EXENDIN-4 BASED DUAL GLP-1/GLUCAGON RECEPTOR AGONIST                 
DBREF  6GE2 A    1    39  UNP    P26349   EXE4_HELSU      48     86             
SEQADV 6GE2 AIB A    2  UNP  P26349    GLY    49 CONFLICT                       
SEQADV 6GE2 GLN A    3  UNP  P26349    GLU    50 CONFLICT                       
SEQADV 6GE2 LYS A   14  UNP  P26349    MET    61 CONFLICT                       
SEQADV 6GE2 ASP A   15  UNP  P26349    GLU    62 CONFLICT                       
SEQADV 6GE2 GLN A   17  UNP  P26349    GLU    64 CONFLICT                       
SEQADV 6GE2 ARG A   18  UNP  P26349    ALA    65 CONFLICT                       
SEQADV 6GE2 ALA A   19  UNP  P26349    VAL    66 CONFLICT                       
SEQADV 6GE2 LYS A   20  UNP  P26349    ARG    67 CONFLICT                       
SEQADV 6GE2 AIB A   27  UNP  P26349    LYS    74 CONFLICT                       
SEQADV 6GE2 ALA A   28  UNP  P26349    ASN    75 CONFLICT                       
SEQADV 6GE2 PRO A   32  UNP  P26349    SER    79 CONFLICT                       
SEQADV 6GE2 AIB A   34  UNP  P26349    GLY    81 CONFLICT                       
SEQADV 6GE2 LYS A   35  UNP  P26349    ALA    82 CONFLICT                       
SEQADV 6GE2 LYS A   39  UNP  P26349    SER    86 CONFLICT                       
SEQADV 6GE2 NH2 A   40  UNP  P26349              AMIDATION                      
SEQRES   1 A   40  HIS AIB GLN GLY THR PHE THR SER ASP LEU SER LYS GLN          
SEQRES   2 A   40  LYS ASP GLU GLN ARG ALA LYS LEU PHE ILE GLU TRP LEU          
SEQRES   3 A   40  AIB ALA GLY GLY PRO PRO SER AIB LYS PRO PRO PRO LYS          
SEQRES   4 A   40  NH2                                                          
HET    AIB  A   2      13                                                       
HET    AIB  A  27      13                                                       
HET    AIB  A  34      13                                                       
HET    NH2  A  40       3                                                       
HET    EVT  A 101      78                                                       
HETNAM     AIB ALPHA-AMINOISOBUTYRIC ACID                                       
HETNAM     NH2 AMINO GROUP                                                      
HETNAM     EVT (2~{S})-2-[[(4~{S})-4-(HEXADECANOYLAMINO)-5-OXIDANYL-5-          
HETNAM   2 EVT  OXIDANYLIDENE-PENTANOYL]AMINO]PENTANEDIOIC ACID                 
FORMUL   1  AIB    3(C4 H9 N O2)                                                
FORMUL   1  NH2    H2 N                                                         
FORMUL   2  EVT    C26 H46 N2 O8                                                
HELIX    1 AA1 GLY A    4  GLY A   30  1                                  27    
HELIX    2 AA2 PRO A   31  AIB A   34  5                                   4    
LINK         C   HIS A   1                 N   AIB A   2     1555   1555  1.35  
LINK         C   AIB A   2                 N   GLN A   3     1555   1555  1.35  
LINK         NZ  LYS A  14                 C33 EVT A 101     1555   1555  1.35  
LINK         C   LEU A  26                 N   AIB A  27     1555   1555  1.36  
LINK         C   AIB A  27                 N   ALA A  28     1555   1555  1.35  
LINK         C   SER A  33                 N   AIB A  34     1555   1555  1.35  
LINK         C   AIB A  34                 N   LYS A  35     1555   1555  1.36  
LINK         C   LYS A  39                 N   NH2 A  40     1555   1555  1.35  
SITE     1 AC1  4 LEU A  10  SER A  11  LYS A  14  ARG A  18                    
SITE     1 AC2  5 TRP A  25  PRO A  31  PRO A  32  SER A  33                    
SITE     2 AC2  5 PRO A  36                                                     
CRYST1    1.000    1.000    1.000  90.00  90.00  90.00 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      1.000000  0.000000  0.000000        0.00000                         
SCALE2      0.000000  1.000000  0.000000        0.00000                         
SCALE3      0.000000  0.000000  1.000000        0.00000                         
MODEL        1